Nakanishi Inc. (TYO:7716)
Japan · Delayed Price · Currency is JPY 2,058.00
-22.00 (-1.06%)
Aug 13, 2025, 3:30 PM JST
Nakanishi Revenue
Nakanishi had revenue of 20.65B JPY in the quarter ending June 30, 2025, with 1.22% growth. This brings the company's revenue in the last twelve months to 77.67B, up 10.98% year-over-year. In the year 2024, Nakanishi had annual revenue of 77.04B with 29.06% growth.
Revenue (ttm)
77.67B
Revenue Growth
+10.98%
P/S Ratio
2.24
Revenue / Employee
35.63M
Employees
2,180
Market Cap
173.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77.04B | 17.35B | 29.06% |
| Dec 31, 2023 | 59.69B | 11.02B | 22.64% |
| Dec 31, 2022 | 48.67B | 3.81B | 8.50% |
| Dec 31, 2021 | 44.86B | 11.80B | 35.70% |
| Dec 31, 2020 | 33.06B | -2.36B | -6.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| HOYA Corporation | 876.09B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |